Healthcare & Life Sciences
Weekly Roundup
Weekly Brief — Healthcare & Life Sciences
Ministry of Ayush Mandates Perpetual Licensing; NHA Escalates AI-Health Integration
This report covers Healthcare policy, Ayushman Bharat, pharmaceuticals, and digital health from July 19, 2026 to July 26, 2026. Findings highlight a landmark shift in drug licensing validity and the deployment of AI-driven digital public goods.
Key Statistics
| 94.87 Crore | ₹1.91 Lakh Crore | 1.29 Lakh |
|---|---|---|
| ABHA IDs Created | Cashless PM-JAY Treatments | MBBS Seats Available |
Weekly Executive Summary
- Regulatory Reform: The Ministry of Ayush notified the "Drugs (Eleventh Amendment) Rules, 2026," transitioning manufacturing licenses for Ayurvedic, Siddha, and Unani (ASU) drugs to a perpetual validity model.
- Digital Health Scaling: The National Health Authority (NHA) successfully tested the National Health Claims Exchange (NHCX) for faster claim settlements and integrated 2 crore OPD tokens via "Scan and Share."
- Global Trade Headwinds: The pharmaceutical sector entered crisis talks following US reports of a 100-200% tariff regime on generic imports starting August 2026, threatening India's 40% market share in US generics.
Deep Dive: Key Devel…
Download Full Intelligence Brief (PDF)
Sign in to your PolicyIndex account to download the complete executive-ready PDF report including all policy exhibits, data tables, and strategic recommendations.
Log In to Download PDF Brief →